Virtu Financial LLC

Position in ATNM — Actinium Pharmaceuticals, Inc.

CIK 1533964 New York, NY

Position in ATNM

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$12,262

-$13,584 QoQ

Shares Held

12,324

-10.4% QoQ

Ownership

0.039%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Virtu Financial LLC holds $51,538,389 across 141 Biotechnology names. ATNM ranks #131 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TERN	Terns Pharmaceuticals, Inc.	70,715	$3,728,094
2	VRTX	Vertex Pharmaceuticals Inc / Ma	7,634	$3,408,886
3	CNTA	Centessa Pharmaceuticals plc	67,775	$2,692,023
4	APLS	Apellis Pharmaceuticals, Inc.	54,785	$2,204,000
5	BMRN	Biomarin Pharmaceutical Inc	38,479	$2,173,678
6	IBRX	ImmunityBio, Inc.	262,298	$2,011,825
7	KALA	KALA BIO, Inc.	152,197	$1,316,504
8	IMUX	Immunic, Inc.	113,366	$1,258,362

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$12,262	12,324	-10.4%	Shares	Defined	2026-05-14
2024-09-30	$25,846	13,748	-34.4%	Shares	Defined	2024-11-20
2024-06-30	$155,178	20,970	-74.4%	Shares	Defined	2024-08-09
2024-03-31	$642,287	82,029	+319.2%	Shares	Defined	2024-05-20
2023-12-31	$99,415	19,570	-9.6%	Shares	Defined	2024-02-26
2023-03-31	$204,592	21,650	-19.4%	Shares	Defined	2023-05-01
2022-12-31	$285,995	26,854	+113.3%	Shares	Defined	2023-02-15
2022-09-30	$92,914	12,590	-64.8%	Shares	Defined	2022-11-07
2022-06-30	$172,145	35,789	+154.0%	Shares	Defined	2022-08-09
2022-03-31	$71,999	14,090	+0.5%	Shares	Defined	2022-05-17
2021-12-31	$84,260	14,020	-49.1%	Shares	Defined	2022-02-17
2020-12-31	$214,687	27,524	—	Shares	Defined	2021-02-24
No filing history on record for this holder in this stock.